330 related articles for article (PubMed ID: 29578103)
1. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD.
Elbehairy AF; Webb KA; Laveneziana P; Domnik NJ; Neder JA; O'Donnell DE;
Respir Physiol Neurobiol; 2018 Jun; 252-253():64-71. PubMed ID: 29578103
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
3. The effect of long-acting dual bronchodilator therapy on exercise tolerance, dynamic hyperinflation, and dead space during constant work rate exercise in COPD.
Stringer WW; Porszasz J; Cao M; Rossiter HB; Siddiqui S; Rennard S; Casaburi R
J Appl Physiol (1985); 2021 Jun; 130(6):2009-2018. PubMed ID: 33914661
[TBL] [Abstract][Full Text] [Related]
4. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.
Borel B; Wilkinson-Maitland CA; Hamilton A; Bourbeau J; Perrault H; Jensen D; Maltais F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2991-3000. PubMed ID: 27942208
[TBL] [Abstract][Full Text] [Related]
5. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD.
Peters MM; Webb KA; O'Donnell DE
Thorax; 2006 Jul; 61(7):559-67. PubMed ID: 16467067
[TBL] [Abstract][Full Text] [Related]
6. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance.
Elbehairy AF; Ciavaglia CE; Webb KA; Guenette JA; Jensen D; Mourad SM; Neder JA; O'Donnell DE;
Am J Respir Crit Care Med; 2015 Jun; 191(12):1384-94. PubMed ID: 25826478
[TBL] [Abstract][Full Text] [Related]
8. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
O'Donnell DE; Hamilton AL; Webb KA
J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
[TBL] [Abstract][Full Text] [Related]
9. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
O'Donnell DE; Lam M; Webb KA
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
[TBL] [Abstract][Full Text] [Related]
10. Sensory-mechanical effects of a dual bronchodilator and its anticholinergic component in COPD.
O'Donnell DE; Elbehairy AF; Faisal A; Neder JA; Webb KA;
Respir Physiol Neurobiol; 2018 Jan; 247():116-125. PubMed ID: 28993264
[TBL] [Abstract][Full Text] [Related]
11. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD.
Guenette JA; Webb KA; O'Donnell DE
Respir Med; 2013 May; 107(5):708-16. PubMed ID: 23421968
[TBL] [Abstract][Full Text] [Related]
12. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
Aliverti A; Rodger K; Dellacà RL; Stevenson N; Lo Mauro A; Pedotti A; Calverley PM
Thorax; 2005 Nov; 60(11):916-24. PubMed ID: 15994253
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
14. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.
O'Donnell DE; Sciurba F; Celli B; Mahler DA; Webb KA; Kalberg CJ; Knobil K
Chest; 2006 Sep; 130(3):647-56. PubMed ID: 16963658
[TBL] [Abstract][Full Text] [Related]
15. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
16. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
Elbehairy AF; O'Donnell CD; Abd Elhameed A; Vincent SG; Milne KM; James MD; Webb KA; Neder JA; O'Donnell DE;
J Appl Physiol (1985); 2019 Oct; 127(4):1107-1116. PubMed ID: 31369329
[TBL] [Abstract][Full Text] [Related]
17. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.
O'Donnell DE; Flüge T; Gerken F; Hamilton A; Webb K; Aguilaniu B; Make B; Magnussen H
Eur Respir J; 2004 Jun; 23(6):832-40. PubMed ID: 15218994
[TBL] [Abstract][Full Text] [Related]
18. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
[TBL] [Abstract][Full Text] [Related]
19. Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exercise.
Calligaro GL; Raine RI; Bateman ME; Bateman ED; Cooper CB
COPD; 2014 Feb; 11(1):105-12. PubMed ID: 24152211
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD.
Mahler DA; Fierro-Carrion G; Mejia-Alfaro R; Ward J; Baird JC
Med Sci Sports Exerc; 2005 Apr; 37(4):529-35. PubMed ID: 15809548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]